| P2093 | author name string | H F DeLuca | |
| P2860 | cites work | The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand | Q22253199 |
| | The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus | Q24318580 |
| | Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine | Q24618361 |
| | Cloning and expression of full-length cDNA encoding human vitamin D receptor | Q24650952 |
| | 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis | Q28248764 |
| | Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning | Q28508915 |
| | Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats | Q28568682 |
| | Cloning and expression of rat 25-hydroxyvitamin D3-1alpha-hydroxylase cDNA | Q28575764 |
| | Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA | Q28583063 |
| | De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase | Q28591006 |
| | Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors | Q29615768 |
| | Vitamin D and adaptation to dietary calcium and phosphate deficiencies increase intestinal plasma membrane calcium pump gene expression | Q30454073 |
| | Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles. | Q53528210 |
| | Synthesis of (26,27- 3 H)-25-hydroxycholecalciferol. | Q53726309 |
| | Rickets and Alopecia with Resistance to 1,25-Dihydroxyvitamin D: Two Different Clinical Courses with Two Different Cellular Defects* | Q54490810 |
| | THE INDUCTION OF GROWTH PROMOTING AND CALCIFYING PROPERTIES IN A RATION BY EXPOSURE TO LIGHT. | Q54562065 |
| | Vitamin D metabolism: the role of kidney tissue. | Q54633053 |
| | Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis | Q56531946 |
| | Response of Intestinal Calcium Transport and Bone Calcium Mobilization to 1,25-Dihydroxyvitamin Da in Thyroparathyroidectomized Rats1 | Q57692170 |
| | 1,25-Dihydroxycholecalciferol: Metabolite of Vitamin D3 Active on Bone in Anephric Rats | Q57692228 |
| | The Response of Intestinal Calcium Transport to 25-Hydroxy and 1,25-Dihydroxy Vitamin D in Nephrectomized Rats | Q57692233 |
| | Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite | Q59089758 |
| | A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia | Q33223289 |
| | UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. | Q33778814 |
| | A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation | Q34159735 |
| | Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine | Q34206777 |
| | Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. | Q34207635 |
| | Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme | Q34386615 |
| | No 1,25-dihydroxyvitamin D3 receptors on osteoclasts of calcium-deficient chicken despite demonstrable receptors on circulating monocytes | Q34519978 |
| | 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. | Q34698001 |
| | Control of 25-hydroxycholecalciferol metabolism by parathyroid glands | Q34712653 |
| | Vitamin D and autoimmune diabetes | Q35042163 |
| | Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand | Q35230672 |
| | Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3 | Q35462970 |
| | Ligand-specific structural changes in the vitamin D receptor in solution | Q35636446 |
| | Supplementation by vitamin D compounds does not affect colonic tumor development in vitamin D sufficient murine models | Q35808511 |
| | Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor | Q36001269 |
| | 1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis | Q36297015 |
| | Biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. | Q36476330 |
| | Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia | Q36576317 |
| | Vitamin D deficiency and renal calcium transport in the rat | Q36993070 |
| | TRPV6 is not required for 1alpha,25-dihydroxyvitamin D3-induced intestinal calcium absorption in vivo | Q37019007 |
| | Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3 | Q37178523 |
| | CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo | Q37203967 |
| | 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis | Q37445672 |
| | Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 21,25-dihydroxycholecalciferol | Q37486177 |
| | Where is the vitamin D receptor? | Q38002664 |
| | Severity of experimental autoimmune encephalomyelitis is unexpectedly reduced in mice born to vitamin D-deficient mothers | Q38345928 |
| | THE RELATIONSHIP BETWEEN VITAMIN D AND PARATHYROID HORMONE | Q40311046 |
| | Calcium transport in epithelial cells of the intestine and kidney | Q40538185 |
| | Current understanding of the molecular actions of vitamin D. | Q40838113 |
| | Studies upon the mode of action of vitamin D: The influence of vitamin D on the absorption of calcium and phosphorus in the rat. | Q41781540 |
| | Site of 1,25(OH)2 vitamin D3 synthesis in the kidney | Q43812165 |
| | Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid | Q43891144 |
| | Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide | Q44831402 |
| | Mutations in CYP24A1 and idiopathic infantile hypercalcemia | Q45345347 |
| | Suppression of experimental autoimmune encephalomyelitis by 300-315nm ultraviolet light | Q45769946 |
| | Hypercalcemia produced by parathyroid hormone suppresses experimental autoimmune encephalomyelitis in female but not male mice. | Q46719754 |
| | 2MD, a new anabolic agent for osteoporosis treatment | Q46954815 |
| | Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice | Q47670597 |
| | Calbindin D9k is not required for 1,25-dihydroxyvitamin D3-mediated Ca2+ absorption in small intestine. | Q51770387 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin D | Q175621 |
| P304 | page(s) | 917-929 | |
| P577 | publication date | 2013-12-20 | |
| P1433 | published in | Journal of Animal Science | Q2046195 |
| P1476 | title | Triennial Growth Symposium--Vitamin D: bones and beyond | |
| P478 | volume | 92 | |